ArticleHeliyon2024

Cost-effectiveness of multigene sequencing test and treatment for metastatic non-small cell lung cancer: A unique setting in the initial adoption phase in Japan allowing testing only after standard treatment.

Naoko Shiraiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.